Cardiac amyloidosis: Better detection and new treatments

Cardiac amyloidosis is a rare heart condition that causes the walls of the heart to become thick, stiff, and unable to pump normally. Three FDA-approved medications for the most common form, ATTR-CM, slow disease progression and extend life.

Content restricted. Requires subscription